| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 03/29/2007 | US20070072835 Method of preparing and use of prodrugs of betulinic acid derivatives |
| 03/27/2007 | US7196208 Chemical intermediate; carbonylation using carbon monoxide using palladium catalyst |
| 03/27/2007 | US7196074 Hormone replacement therapy |
| 03/21/2007 | CN1305890C 17a-fluoroalkyl steroids method for producing the same and pharmaceutical compositions containing said compounds |
| 03/20/2007 | US7192942 Wet milling while crystallizing to obtain a primary particle suspension. |
| 03/15/2007 | US20070059239 Process for the preparation of radioactive labeled estradiol |
| 03/14/2007 | CN1930181A Helix 12 directed pharmaceutical products |
| 03/14/2007 | CN1304413C Process for preparing anti-cancer medicine Exemestane |
| 03/13/2007 | CA2420895C Method for treating erectile dysfunction and increasing libido in men |
| 03/07/2007 | EP1758919A1 Estrogen receptor modulators |
| 03/07/2007 | EP1406591B1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 03/07/2007 | EP1267885B1 Male contraceptive formulation comprising norethisterone and testosterone undecanoate |
| 03/07/2007 | CN1923841A 7 alpha-substituted 11 alpha-hydroxysteroids and its microbiological production method |
| 03/06/2007 | US7186707 Prodrugs for use as ophthalmic agents |
| 03/01/2007 | WO2007024338A2 3 -ester prodrugs of ethynylestradiol |
| 03/01/2007 | CA2610475A1 Derivative prodrugs of ethinyl estradiol |
| 02/28/2007 | EP1756139A2 Antiangiogenic agents |
| 02/28/2007 | CN1919199A Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 02/27/2007 | US7182960 Pharmaceutical compositions for nasal delivery of oestradiol and norethisterone |
| 02/22/2007 | US20070043007 Specific glucocorticosteroid compounds having anti-inflammatory activity |
| 02/21/2007 | EP1562974B1 Processes for preparing c-7 substituted 5-androstenes |
| 02/20/2007 | US7179799 (3) and (6) substituted estrogenic compounds |
| 02/14/2007 | EP1490392B1 Steroidal quinols as prodrugs of antioxidants |
| 02/08/2007 | WO2007014711A1 17-alpha-substituted derivatives of estradiol with wound-healing activity |
| 02/08/2007 | WO2006081152A3 Estrogen receptor modulators |
| 02/08/2007 | US20070032462 Novel methods for the preparation of dhea derivatives |
| 02/07/2007 | CN1298730C Steroid framework compound, synthesizing process and its use |
| 02/01/2007 | US20070027117 Novel glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 01/31/2007 | CN1906207A Di-steroidal prodrugs of ethinyl estradiol |
| 01/31/2007 | CN1906206A Di-steroidal prodrugs of estradiol |
| 01/30/2007 | US7169769 17α-hydroxy-14β-steroids with hormonal effect |
| 01/30/2007 | US7169611 Programmable genotoxic agents and uses therefor |
| 01/25/2007 | US20070021624 Steroid sulphatase inhibitors |
| 01/18/2007 | WO2007008474A2 3 -ester prodrugs of estradiol |
| 01/18/2007 | CA2610481A1 3-ester prodrugs of estradiol |
| 01/11/2007 | US20070010505 Methods of treating disease states using antiangiogenic agents |
| 01/04/2007 | US20070004689 Antiangiogenic agents |
| 01/03/2007 | CN1293090C 9-alpha-substituted estratrienes as selectively active estrogens |
| 01/02/2007 | CA2168850C Estrogenic compounds as anti-mitotic agents |
| 12/28/2006 | WO2006072955A3 Physiologically synergistic mixtures of fruit components, methods of preparation thereof and methods of use thereof |
| 12/27/2006 | EP1525214B1 Process and new intermediates for the preparation of steroids with a progestogen activity |
| 12/27/2006 | EP1513861B1 New etonogestrel esters |
| 12/27/2006 | CN1886418A 雌激素受体调节剂 Estrogen receptor modulators |
| 12/26/2006 | US7153844 Estrogen-linked platinum (II) complexes as anticancer agents |
| 12/26/2006 | US7153522 bases comprising isoprene-styrene block copolymer and/or polyisobutylene, softeners and tackifier resins, hexylene glycol and 1-menthol as skin absorption intensifiers, and hormones as the drug components |
| 12/20/2006 | CN1882606A 雌激素受体调节剂 Estrogen receptor modulators |
| 12/20/2006 | CN1879630A Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
| 12/20/2006 | CN1879629A Estrogen replacement therapy |
| 12/19/2006 | CA2365083C Process for producing 4,4-dimethyl-3.beta.-hydrocypregna-8,14-diene-21-carboxylic acid esters and intermediate products obtained by said process |
| 12/14/2006 | US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 12/13/2006 | EP1731157A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
| 12/13/2006 | CN1878786A Novel 17beta-hydroxysteroid dehydrogenase type i inhibitors |
| 12/12/2006 | US7148213 Steroids with fluoroalkyl groups as antigestation steroids used in gynecological treatment |
| 12/12/2006 | US7148212 Subjecting a supersaturated solution containing a steroid to wet milling while crystallizing, in order to obtain a primary particle suspension. |
| 12/12/2006 | CA2154161C Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 11/30/2006 | WO2006125453A1 Process for the preparation of pure crystalline tibolone |
| 11/30/2006 | US20060270845 16 alpha - and 16 beta -hydroxy-estra-1,3,5(10)-estratrienes, which carry additional substituents on the steroid skeleton and can have one or more additional double bonds in the B-, C- and/or D-rings; higher affinity to estrogen receptors from rat prostates than to estrogen receptors from rat uteri |
| 11/29/2006 | EP1726307A2 Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 11/29/2006 | CN1871251A Novel triterpene derivatives, preparation thereof and use thereof |
| 11/29/2006 | CN1286847C Separation of cresol from mare's urine |
| 11/28/2006 | US7141559 Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 11/23/2006 | US20060264412 Carbonylation; hydrogenation; for preparation of eplerenone |
| 11/22/2006 | EP1722779A1 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents |
| 11/22/2006 | CN1865276A Method for synthesizing steroid progestogen |
| 11/21/2006 | US7138520 Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same |
| 11/21/2006 | US7138376 Composition for treating a host infected with a hepatitis C viral comprising administering an effective hepatitis C treatment amount of a described 4'-disubstituted nucleoside or a pharmaceutically acceptable salt or prodrug thereof |
| 11/15/2006 | CN1863814A Process for the preparation of 7-alpha-methylsteroids |
| 11/14/2006 | US7135581 For therapy of disease states characterized by abnormal cell mitosis and abnormal angiogenesis |
| 11/02/2006 | US20060247219 Specific glucocorticosteriod compound having anti-inflamatory activity |
| 10/25/2006 | EP1219632B1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds |
| 10/25/2006 | CN1852918A Methods and compositions for interferon therapy |
| 10/25/2006 | CN1850842A 4-chlorobenzoicacid prasterone and its synthesizing method |
| 10/25/2006 | CN1850841A 5 alpha-androstane-17-one-3beta alcohol ester, and its preparing method and use |
| 10/25/2006 | CN1850840A 2-oxa-5 alpha-androstane-3-one-17 alcohol ester, and its preparing method and use |
| 10/24/2006 | US7125975 Derivatized oligonucleotides having improved uptake and other properties |
| 10/19/2006 | US20060234994 Method and device for concentrating and stabilizing conjugated estrogens from mare urine |
| 10/18/2006 | CN1849330A Specific glucocorticosteroid compound having anti-inflammatory activity |
| 10/17/2006 | US7122649 Derivatized oligonucleotides having improved uptake and other properties |
| 10/17/2006 | CA2207622C Intravaginal drug delivery devices for the administration of 17.beta.-oestradiol precursors |
| 10/11/2006 | EP1709062A1 Exemestane and its intermediates and methods of making the same |
| 10/11/2006 | EP1709061A1 Di-steroidal prodrugs of ethinyl estradiol |
| 10/11/2006 | EP1709060A1 Di-steroidal prodrugs of estradiol |
| 10/11/2006 | EP0894000B1 Use for delivering estrogen |
| 10/11/2006 | CN1845933A Specific glucocorticosteriod compound having anti-inflamatory activity |
| 10/11/2006 | CN1845932A Transfection agents |
| 10/10/2006 | US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates |
| 10/10/2006 | CA2273343C Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 10/05/2006 | WO2006033907A3 Methods of treating disorders having a component of mercury toxicity |
| 09/27/2006 | EP1704161A1 Helix 12 directed steroidal pharmaceutical products |
| 09/27/2006 | EP0957921B1 17alpha-dihydroequilenin for preventing neurodegeneration and cognitive dysfunction |
| 09/27/2006 | CN1839145A Steroid spirolactonization |
| 09/27/2006 | CN1837231A Immunomodulatory steroids, in particular the hemihydrate of 16, alpha-bromoepiandrosterone |
| 09/26/2006 | US7112670 Crystal form |
| 09/26/2006 | US7112669 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 09/21/2006 | US20060211857 6,7-Oxygenated steroids and uses related thereto |
| 09/21/2006 | US20060211670 Antitumoral18a-homoestra-1,3,5(10)-trien-3yl 2-substituted sulfamates |
| 09/21/2006 | US20060211669 Synthesis of estetrol via estrone derived steroids |
| 09/21/2006 | US20060211664 Method for treating erectile dysfunction and increasing libido in men |
| 09/20/2006 | EP1497308B1 Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations |
| 09/20/2006 | CN1835964A Target-oriented chemotherapy for treating tumors of the sexual organs |